Cytokinetics, Inc. (CYTK)
77.09
+0.25
(+0.33%)
USD |
NASDAQ |
Aug 24, 16:00
77.09
0.00 (0.00%)
After-Hours: 19:59
Cytokinetics Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 27, 2024 | 56.67 |
| September 26, 2024 | 56.98 |
| September 25, 2024 | 57.04 |
| September 24, 2024 | 57.01 |
| September 23, 2024 | 56.40 |
| September 20, 2024 | 58.22 |
| September 19, 2024 | 60.20 |
| September 18, 2024 | 60.57 |
| September 17, 2024 | 60.80 |
| September 16, 2024 | 61.44 |
| September 13, 2024 | 60.50 |
| September 12, 2024 | 58.53 |
| September 11, 2024 | 58.22 |
| September 10, 2024 | 58.63 |
| September 09, 2024 | 60.45 |
| September 06, 2024 | 58.56 |
| September 05, 2024 | 60.55 |
| September 04, 2024 | 59.43 |
| September 03, 2024 | 59.07 |
| August 30, 2024 | 61.80 |
| August 29, 2024 | 62.14 |
| August 28, 2024 | 60.12 |
| August 27, 2024 | 60.47 |
| August 26, 2024 | 61.79 |
| August 23, 2024 | 62.06 |
| Date | Value |
|---|---|
| August 22, 2024 | 60.90 |
| August 21, 2024 | 61.26 |
| August 20, 2024 | 61.55 |
| August 19, 2024 | 61.13 |
| August 16, 2024 | 61.17 |
| August 15, 2024 | 61.78 |
| August 14, 2024 | 60.50 |
| August 13, 2024 | 60.71 |
| August 12, 2024 | 60.83 |
| August 09, 2024 | 60.40 |
| August 08, 2024 | 58.46 |
| August 07, 2024 | 55.46 |
| August 06, 2024 | 57.97 |
| August 05, 2024 | 57.85 |
| August 02, 2024 | 61.86 |
| August 01, 2024 | 62.70 |
| July 31, 2024 | 63.89 |
| July 30, 2024 | 65.13 |
| July 29, 2024 | 63.98 |
| July 26, 2024 | 64.63 |
| July 25, 2024 | 63.34 |
| July 24, 2024 | 61.50 |
| July 23, 2024 | 62.12 |
| July 22, 2024 | 62.17 |
| July 19, 2024 | 61.07 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Krystal Biotech, Inc. | 7.442 |
| Ionis Pharmaceuticals, Inc. | 23.36 |
| Bristol Myers Squibb Co. | 6.161 |
| Gilead Sciences, Inc. | 15.40 |
| Rigel Pharmaceuticals, Inc. | 1.980 |
Price to Book Value Related Metrics
| PS Ratio | 141.77 |
| PEG Ratio | -0.2601 |
| Price | 77.09 |
| Earnings Yield | -9.37% |
| Market Cap | 10.70B |
| PEGY Ratio | -0.2601 |